Catherine Daniel

682 total citations
43 papers, 423 citations indexed

About

Catherine Daniel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Catherine Daniel has authored 43 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 8 papers in Surgery. Recurrent topics in Catherine Daniel's work include Lung Cancer Treatments and Mutations (11 papers), Pleural and Pulmonary Diseases (7 papers) and Occupational and environmental lung diseases (6 papers). Catherine Daniel is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Pleural and Pulmonary Diseases (7 papers) and Occupational and environmental lung diseases (6 papers). Catherine Daniel collaborates with scholars based in France, United States and Italy. Catherine Daniel's co-authors include Karim Fizazi, H. Doubre, A. Fandi, Pierre Ruffiè, J. Viala, Thierry Le Chevalier, Philippe Barthélémy, A. Riviére, Jacquelyn M. Powers and Timothy L. McCavit and has published in prestigious journals such as Journal of Clinical Oncology, Biochemistry and Cancer Research.

In The Last Decade

Catherine Daniel

41 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Daniel France 11 260 128 63 50 45 43 423
Nicole Ng United States 13 155 0.6× 72 0.6× 42 0.7× 73 1.5× 45 1.0× 37 368
Lee Hartner United States 10 217 0.8× 135 1.1× 28 0.4× 84 1.7× 46 1.0× 26 414
Geetika Srivastava United States 9 108 0.4× 153 1.2× 47 0.7× 144 2.9× 107 2.4× 31 411
Carol Zhao United States 14 459 1.8× 139 1.1× 42 0.7× 86 1.7× 13 0.3× 30 623
Beáta Mladosievičová Slovakia 11 82 0.3× 112 0.9× 71 1.1× 82 1.6× 55 1.2× 61 399
Lok Lam Ngai Netherlands 9 178 0.7× 116 0.9× 130 2.1× 54 1.1× 98 2.2× 17 370
Jules L.L.M. Coenen Netherlands 12 261 1.0× 195 1.5× 17 0.3× 52 1.0× 75 1.7× 20 469
Jyotsna Fuloria United States 12 126 0.5× 172 1.3× 148 2.3× 75 1.5× 23 0.5× 30 363
A. Schilf France 4 172 0.7× 365 2.9× 96 1.5× 59 1.2× 16 0.4× 7 496
B. Melosky Canada 9 137 0.5× 210 1.6× 31 0.5× 68 1.4× 48 1.1× 22 433

Countries citing papers authored by Catherine Daniel

Since Specialization
Citations

This map shows the geographic impact of Catherine Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Daniel more than expected).

Fields of papers citing papers by Catherine Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Daniel. The network helps show where Catherine Daniel may publish in the future.

Co-authorship network of co-authors of Catherine Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Daniel. A scholar is included among the top collaborators of Catherine Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Daniel. Catherine Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dall’Olio, Filippo Gustavo, Bastien Job, Stefan Michiels, et al.. (2024). Genomic instability in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/ IFCT1301 trial.. Journal of Clinical Oncology. 42(16_suppl). 2632–2632. 1 indexed citations
2.
Dall’Olio, Filippo Gustavo, Damien Vasseur, Maryam Karimi, et al.. (2023). Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial.. Journal of Clinical Oncology. 41(16_suppl). 2516–2516.
3.
4.
Zemoura, L., Catherine Daniel, Samia Melaabi, et al.. (2022). Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report. Lung Cancer. 174. 186–187. 5 indexed citations
5.
6.
Basse, Clémence, et al.. (2021). Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center. Lung Cancer. 157. 79–84. 6 indexed citations
7.
8.
Daniel, Catherine, et al.. (2020). Congenital Diaphragmatic Hernia in an Adult Patient. The American Journal of Medicine. 134(1). e4–e5. 1 indexed citations
9.
Auliac, J.B., M. Pérol, David Planchard, et al.. (2018). Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation. Lung Cancer. 127. 96–102. 31 indexed citations
10.
Deberne, M., Stanislas Ropert, Bertrand Billemont, et al.. (2014). Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?. BMC Cancer. 14(1). 416–416. 17 indexed citations
11.
Daniel, Catherine. (2012). [Lung cancer, a worrying epidemiological evolution].. PubMed. 14–6. 4 indexed citations
12.
Borget, Isabelle, Jacques Cadranel, Jean‐Pierre Pignon, et al.. (2011). Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. European Respiratory Journal. 39(1). 172–179. 27 indexed citations
13.
Wolkow, Natalie, et al.. (2011). Prochelators triggered by hydrogen peroxide provide hexadentate iron coordination to impede oxidative stress. Journal of Inorganic Biochemistry. 105(9). 1161–1172. 29 indexed citations
14.
Daniel, Catherine, et al.. (2008). Utilisation du cathéter à chambre implantable pleural dans la gestion des pleurésies malignes Expérience de l’Institut Curie. Revue de Pneumologie Clinique. 64(1). 8–14. 1 indexed citations
15.
Daniel, Catherine, et al.. (2007). Use of a Pleural Implantable Access System for the Management of Malignant Pleural Effusion: The Institut Curie Experience. The Annals of Thoracic Surgery. 84(4). 1367–1370. 8 indexed citations
16.
Chahory, Sabine, Laura Padrón-Barthe, Catherine Daniel, Nicole Keller, & Alicia Torriglia. (2006). Involvement of the LEI/L–DNase II Pathway in Light–Induced Retinal Degeneration. Investigative Ophthalmology & Visual Science. 47(13). 2045–2045. 1 indexed citations
17.
Daniel, Catherine, Karim Fizazi, Stéphane Culine, et al.. (2001). Metachronous gonadal and extragonadal primaries, or late relapse of germ cell tumor?. Urologic Oncology Seminars and Original Investigations. 6(2). 49–52. 14 indexed citations
18.
19.
20.
Persechini, Pedro M., et al.. (1992). Channel-forming activity of the perforin N-terminus and a putative .alpha.-helical region homologous with complement C9. Biochemistry. 31(21). 5017–5021. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Ng Breakdown of academic impact, for papers by Lee Hartner Breakdown of academic impact, for papers by Geetika Srivastava Breakdown of academic impact, for papers by Carol Zhao Breakdown of academic impact, for papers by Beáta Mladosievičová Breakdown of academic impact, for papers by Lok Lam Ngai Breakdown of academic impact, for papers by Jules L.L.M. Coenen Breakdown of academic impact, for papers by Jyotsna Fuloria Breakdown of academic impact, for papers by A. Schilf Breakdown of academic impact, for papers by B. Melosky
Rankless by CCL
2026